Arcutis Biotherapeutics
Clea T. is a seasoned professional in manufacturing process technology, currently serving as Senior Director at Arcutis Biotherapeutics, Inc. since May 2021, after holding the role of Director within the same company. Prior experience includes over two decades at Amgen, where Clea T. advanced from Senior Principal to Principal Engineer, leading fill-finish process development for a multi-billion dollar program and supporting over 17 new product introductions in clinical and commercial manufacturing. Earlier positions include Process Design Engineer roles at FMC, The Scotts Miracle-Gro Company, and Albemarle, focusing on blending systems and facility design. Clea T. holds a Bachelor of Science degree in Chemical Engineering from Tulane University.
This person is not in any teams
This person is not in any offices
Arcutis Biotherapeutics
3 followers
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.